Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amikacin”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Post-approval studies (Phase 4)Study completedNCT00360607
What this trial is testing

A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections

Who this might be right for
Infection
Pfizer 307
Early research (Phase 1)Study completedNCT02897869
What this trial is testing

DDI Study to Investigate Interaction Between Amikacin and POL7080

Who this might be right for
Healthy
Polyphor Ltd. 14
Testing effectiveness (Phase 2)Study completedNCT01315236
What this trial is testing

Liposomal Amikacin for Inhalation (LAI) for Nontuberculous Mycobacteria

Who this might be right for
Mycobacterium Infections, Nontuberculous
Insmed Incorporated 90
Not applicableStudy completedNCT02728518
What this trial is testing

Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

Who this might be right for
Pneumonia
National Heart Institute, Egypt 133
Post-approval studies (Phase 4)Study completedNCT07369336
What this trial is testing

Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia

Who this might be right for
Ventilator Associated Pneumonia ( VAP)
Postgraduate Medical Institute, Lahore 90
Not applicableStudy completedNCT07315438
What this trial is testing

Model-Informed Precision Dosing on Amikacin and Vancomycin Therapy in Critically Ill Children

Who this might be right for
Model Informed Precision Dosing
Hacettepe University 41
Large-scale testing (Phase 3)WithdrawnNCT01315691
What this trial is testing

Study to Evaluate Arikace™ in CF Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Insmed Incorporated
Not applicableUnknownNCT04867993
What this trial is testing

Amikacin Pharmacokinetics to Optimize Dosing Recommendations in Neonates With Perinatal Asphyxia Treated With Hypothermia

Who this might be right for
Asphyxia Neonatorum
University of Sarajevo 80
Testing effectiveness (Phase 2)Study completedNCT00786305
What this trial is testing

Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia

Who this might be right for
Pneumonia
Groupe Hospitalier Pitie-Salpetriere 40
Large-scale testing (Phase 3)UnknownNCT05213507
What this trial is testing

Inhaled Amikacin in Preventing AECOPD

Who this might be right for
COPDCOPD Exacerbation
Shanghai Zhongshan Hospital 136
Not applicableUnknownNCT02538588
What this trial is testing

Comparison of Amikacin Lung Delivery With Two Nebulizers

Who this might be right for
HealthyCystic Fibrosis
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 12
Not applicableStudy completedNCT04322019
What this trial is testing

Prescription Strategies of Amikacin in Intensive Care Patients on Renal Replacement Therapy: an Observational Prospective Multicenter Study

Who this might be right for
Amikacin Treatment
CHU de Reims 112
Not applicableLooking for participantsNCT02456974
What this trial is testing

Antibiotic Dosing in Pediatric Intensive Care

Who this might be right for
PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactam+5 more
University Hospital, Ghent 640
Not applicableStudy completedNCT03683511
What this trial is testing

Nomograms for Optimization of Amikacin First Dose in Critically Ill Patients Using a Population Pharmacokinetics Model

Who this might be right for
Pharmacokinetics
Nantes University Hospital 138
Post-approval studies (Phase 4)Study completedNCT02081963
What this trial is testing

Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis

Who this might be right for
Non-Cystic Fibrosis Bronchiectasis
Qilu Hospital of Shandong University 178
Testing effectiveness (Phase 2)WithdrawnNCT01528930
What this trial is testing

Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease

Who this might be right for
Pulmonary Non-tuberculous Mycobacterial Lung Disease
Samsung Medical Center
Not applicableUnknownNCT03990467
What this trial is testing

Observed Pharmacokinetic of Piperacillin/Tazobactam Compared to Amikacin in ICU

Who this might be right for
Septic ShockSepsisSepsis Syndrome
Hospices Civils de Lyon 60
Testing effectiveness (Phase 2)Study completedNCT03038178
What this trial is testing

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

Who this might be right for
Mycobacterium Infections, NontuberculousMycobacteria, Atypical
Kevin Winthrop 30
Testing effectiveness (Phase 2)Looking for participantsNCT06585020
What this trial is testing

Amikacin Liposome Inhalation Suspension for Treatment of Mycobacterium Xenopi Pulmonary Infection

Who this might be right for
Mycobacterium; XenopiLung Diseases
Centre Hospitalier Universitaire, Amiens 190
Not applicableStudy completedNCT00000796
What this trial is testing

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 525
Load More Results